![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 11, 6171-6176, March 13, 1998
From the Department of Chemistry, Purdue University,
West Lafayette, Indiana 47907-1393
Erythrocyte protein 4.1 has been hypothesized to
link the spectrin-actin junctional complex directly to the cytoplasmic
domain of glycophorin C, but this bridging function has never been
directly demonstrated. Because an alternative protein-mediated bridge
between the junctional complex and the cytoplasmic domain of band 3 is also plausible, we have undertaken to characterize the membrane sites
to which protein 4.1 can anchor the spectrin and actin skeleton. We
demonstrate that proteolytic removal of the cytoplasmic domain of band
3 has minimal effect on the ability of protein 4.1 to promote
125I-labeled spectrin and actin binding to
KI-stripped erythrocyte membrane vesicles. We also show that
quantitative blockade of all band 3 sites with either monoclonal or
polyclonal antibodies to band 3 is equally ineffective in preventing
protein 4.1-mediated association of spectrin and actin with the
membrane. In contrast, obstruction of protein 4.1 binding to its
docking site on the cytoplasmic pole of glycophorin C is demonstrated
to reduce the same protein 4.1 bridging function by ~85%. We
conclude from these data that (i) glycophorin C contributes the primary
anchoring site of the protein 4.1-mediated bridge to the spectrin-actin skeleton; (ii) band 3 is incapable of serving the same function; and
(iii) additional minor protein 4.1 bridging sites may exist on the
human erythrocyte membrane.
Biochemical Analysis of Potential Sites for Protein 4.1-mediated
Anchoring of the Spectrin-Actin Skeleton to the Erythrocyte
Membrane
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
L. L. Peters, R. A. Swearingen, S. G. Andersen, B. Gwynn, A. J. Lambert, R. Li, S. E. Lux, and G. A. Churchill Identification of quantitative trait loci that modify the severity of hereditary spherocytosis in wan, a new mouse model of band-3 deficiency Blood, April 15, 2004; 103(8): 3233 - 3240. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Biederer and T. C. Sudhof CASK and Protein 4.1 Support F-actin Nucleation on Neurexins J. Biol. Chem., December 14, 2001; 276(51): 47869 - 47876. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gascard, G. Lee, L. Coulombel, I. Auffray, M. Lum, M. Parra, J.G. Conboy, N. Mohandas, and J.A. Chasis Characterization of Multiple Isoforms of Protein 4.1R Expressed During Erythroid Terminal Differentiation Blood, December 1, 1998; 92(11): 4404 - 4414. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |